percutaneous embolization
Recently Published Documents


TOTAL DOCUMENTS

262
(FIVE YEARS 54)

H-INDEX

23
(FIVE YEARS 2)

2022 ◽  
Vol 17 (3) ◽  
pp. 549-552
Author(s):  
Le Viet Dung ◽  
Nguyen Thai Binh ◽  
Le Tuan Linh ◽  
Phan Nhan Hien ◽  
Tran Ngoc Dung ◽  
...  

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Maria del Mar Schilt-Catafal ◽  
Félix Pastor-Escartín ◽  
Ana Martínez-Piñero ◽  
Paulina Neira-Ibáñez ◽  
Laura Manfreda-Domínguez ◽  
...  

2022 ◽  
Vol 5 (1) ◽  
Author(s):  
Chloé Extrat ◽  
Sylvain Grange ◽  
Clément Chevalier ◽  
Nicolas Williet ◽  
Jean-Marc Phelip ◽  
...  

Abstract Background Patients with spontaneous or traumatic active mesenteric bleeding cannot be treated endoscopically. Transarterial embolization can serve as a potential alternative to emergency surgery. Literature on transarterial embolization for mesenteric bleeding remains very scarce. The objective of this study was to evaluate the safety and efficacy of transarterial embolization for mesenteric bleeding. We reviewed all consecutive patients admitted for mesenteric bleeding to the interventional radiology department, in a tertiary center, between January 2010 and March 2021. Mesenteric bleeding was defined as mesenteric hematoma and contrast extravasation and/or pseudoaneurysm visible on pre-operative CT scan. We evaluated technical success, clinical success, and complications. Results Among the 17 patients admitted to the interventional department for mesenteric bleeding, 15 presented with active mesenteric bleeding requiring transarterial embolization with five patients with hemodynamic instability. Mean age was 67 ± 14 years, including 12 (70.6%) males. Technical success was achieved in 14/15 (93.3%) patients. One patient with technical failure was treated by percutaneous embolization with NBCA-Lipiodol mixture. Three patients (20%) had early rebleeding: two were treated by successful repeat embolization and one by surgery. One patient (6.7%) had early death within 30 days and two patients (13.3%) had late death after 30 days. Mean length of hospitalization was 12.8 ± 7 days. There were no transarterial embolization-related ischemic complications. Conclusion Transarterial embolization is a safe and effective technique for treating mesenteric bleeding even in patients with hemodynamic instability. Transarterial embolization doesn’t close the door to surgery and could be proposed as first intention in case of mesenteric bleeding.


Author(s):  
Daina Martínez-Falguera ◽  
Edgar Fadeuilhe ◽  
Albert Teis ◽  
Julia Aranyo ◽  
Raquel Adeliño ◽  
...  

2021 ◽  
Vol 76 ◽  
pp. 584-586
Author(s):  
Samuel Nussbaum ◽  
Beau Toskich ◽  
Houssam Farres ◽  
Albert Hakaim ◽  
Charles Ritchie

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A966
Author(s):  
NISHANT SHARMA ◽  
Arooj Quadir ◽  
Danish Haque ◽  
William Haas ◽  
Ajinkya Buradkar ◽  
...  

2021 ◽  
pp. 112972982110473
Author(s):  
Pinto Diego ◽  
Montalvo Fabián ◽  
Melendez Constanza ◽  
Lapadula Mirna ◽  
Perez Martin

We present the case of a patient with a brachio-basilic graft forearm loop with intractable edema and thrombosed central veins. She showed up with an important edema after some effort and a previously thrombosed pseudoaneurysm with significant growth. She refused angioplasty treatment for central veins, the graft had not been used for dialysis during the last year, so that arteriovenous graft (AVG) ligation was considered. Due to local conditions thrombin percutaneous embolization was performed to avoid possible complications of a conventional surgery approach. AVG occlusion was done in 10 min by fluoroscopy and ultrasound guidance. In 24 h the patient was significantly better and after 1 week she had no edema at all. There were no complications and no recanalization was observed after 3 months. Percutaneous thrombin embolization is a safe and effective technique for AVG occlusion in case of intractable arm edema with central vein thrombosis, and most likely to be considered in other situations where arteriovenous graft or fistula ligature is needed.


Author(s):  
Rissa U. Setiani ◽  
Edwin A. D. Batubara ◽  
Suko Adiarto ◽  
Taofan Siddiq ◽  
Suci Indriani ◽  
...  

AbstractPelvic congestion syndrome (PCS) is a clinical syndrome supported by specific findings, such as ovarian vein's dilatation, that cause pelvic vein congestion. Although many theories are explaining the pathophysiologies of this condition, the underlying cause remains unknown. The clinical manifestations of PCS are various including chronic pelvic pain (CPP), voiding disturbances, or ureteral obstruction. Imaging modality, such as ultrasonography, computed tomography (CT scan), magnetic resonance imaging (MRI), and venography, are needed to confirm and exclude the differential diagnosis. Currently, American venous forum guidelines recommended endovascular therapy which is percutaneous embolization as the first option therapy of PCS. Here, we reported a 35-year-old woman with PCS who underwent successful percutaneous embolization therapy.


Sign in / Sign up

Export Citation Format

Share Document